Your browser doesn't support javascript.
loading
Spesolimab, an anti-interleukin-36 receptor antibody, in patients with moderate-to-severe atopic dermatitis: Results from a multicentre, randomized, double-blind, placebo-controlled, phase IIa study.
Bissonnette, Robert; Abramovits, William; Saint-Cyr Proulx, Étienne; Lee, Patricia; Guttman-Yassky, Emma; Zovko, Elizabeta; Sigmund, Ralf; Willcox, Joanne; Bieber, Thomas.
Afiliación
  • Bissonnette R; Innovaderm Research Inc., Montreal, Quebec, Canada.
  • Abramovits W; Dermatology Treatment and Research Center, Dallas, Texas, USA.
  • Saint-Cyr Proulx É; Innovaderm Research Inc., Montreal, Quebec, Canada.
  • Lee P; Center for Clinical Studies, Houston, Texas, USA.
  • Guttman-Yassky E; Department of Dermatology and Immunology Institute, Icahn School of Medicine, Mount Sinai, New York, New York, USA.
  • Zovko E; Boehringer Ingelheim Corporation, Ridgefield, Connecticut, USA.
  • Sigmund R; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.
  • Willcox J; Boehringer Ingelheim Pharmaceuticals Ltd, Burlington, Ontario, Canada.
  • Bieber T; Department of Dermatology and Allergy, Christine Kühne-Center for Allergy Research and Education (CK-CARE), University Hospital Bonn, Bonn, Germany.
J Eur Acad Dermatol Venereol ; 37(3): 549-557, 2023 Mar.
Article en En | MEDLINE | ID: mdl-36376738

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Dermatitis Atópica Tipo de estudio: Clinical_trials Límite: Adult / Humans Idioma: En Revista: J Eur Acad Dermatol Venereol Asunto de la revista: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Año: 2023 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Dermatitis Atópica Tipo de estudio: Clinical_trials Límite: Adult / Humans Idioma: En Revista: J Eur Acad Dermatol Venereol Asunto de la revista: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Año: 2023 Tipo del documento: Article País de afiliación: Canadá